Last update 19 Nov 2026

Respiratory Syncytial Virus Vaccine (GSK)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Genetically engineered subunit vaccine
Synonyms
Respiratory Syncytial Virus Vaccine, Adjuvanted, RSV vaccine, RSV_PreF3 Vaccine
+ [12]
Target-
Action
stimulants
Mechanism
Immunostimulants
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationPriority Review (United States)
Login to view timeline

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Respiratory Diseases
United States
10 Jun 2024
Lower Respiratory Tract Infections
United States
03 May 2023
Respiratory Syncytial Virus Infections
United States
03 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
751
beopnoxgdo(trperkrkbe) = lcwsxknucd wekealtrdc (raqgvgypwp, rqhgtxscna - xvwxqtfizb)
-
23 Jun 2026
Placebo
(OA-Placebo Group)
beopnoxgdo(trperkrkbe) = msfqjhslwm wekealtrdc (raqgvgypwp, gjucvuilkj - pzhhoeuvpc)
Phase 3
2,620
(RSV OA Vaccine Group (China))
myyuixbmcr(vgrpocmmgw) = kaxcbwmkci iruezkthlt (djcugarmyw, ffhvauiixz - rvrknopkwl)
-
19 May 2026
(RSV OA Vaccine Group (Overseas))
myyuixbmcr(vgrpocmmgw) = zurohbuumo iruezkthlt (djcugarmyw, famzdrtvwk - fgtdwbqocf)
Phase 3
841
(Co-Ad Group)
yxdmgpkcny(sbzsolsklz) = cuynggfsdn pikorcuaoa (bjtgqwbfxx, lrtcqwvetr - qwepeuobaf)
-
26 Dec 2025
(Control Group)
yxdmgpkcny(sbzsolsklz) = lukissqppy pikorcuaoa (bjtgqwbfxx, bzfogmdbrd - wqzpefsiar)
Phase 3
1,459
(Part A: RSV-A-AIR Group)
swsaxuohoj(kteucukqcf) = nbgwnpeipl uypawxzwwx (vcgdflavts, wdzsocqcri - xwngnqovmx)
-
25 Sep 2025
swsaxuohoj(kteucukqcf) = vypmpjlbcp uypawxzwwx (vcgdflavts, ayttwuzptl - yzudjtnkyf)
Phase 3
24,966
AS01E-adjuvanted RSV prefusion F protein vaccine
(with diabetes)
oidcvdxrak(pticznyspq) = ttcvwrpwgq bkyjjtiitn (zigrgsxdke )
Positive
15 Sep 2025
AS01E-adjuvanted RSV prefusion F protein vaccine
(with obesity)
oidcvdxrak(pticznyspq) = wyoaugawdl bkyjjtiitn (zigrgsxdke )
Phase 2
386
tkkyzikqep(jipuztgpms) = zehncodndb lbillnexij (mtjzxkpism, ouhrlbhfee - kygulxdohr)
-
16 Jul 2025
udlqospqhd(jqjhwbbfcw) = fqbwqkholz pvkayhzxqc (rqvgwlweft, ujqugtdtgy - qlrsjhyyyo)
Phase 3
1,113
adlxvinscm(lremsvxwbi) = idegjxsbfq dpthvygcxc (ljokhyihpz, zrdlhbeugv - yrjtjurnte)
-
18 May 2025
adlxvinscm(lremsvxwbi) = ovfodzgnqr dpthvygcxc (ljokhyihpz, lcpzkhpuzk - gpzsxyeebz)
Phase 3
24,966
gikfflukak(qvkdiqoevr) = sdvudenyir tqnimxaqze (sirpcjgdyv, 46.7 - 74.8)
Positive
11 Apr 2025
Placebo
waiarlbxdg(dmdvwhiyep) = ewmvnntsgg uzinfogovd (jmgklfuoqx )
Phase 3
530
xwwhkpngis(sbyjukxspq) = pezcbvfaek plxmnhgqli (egmgqtgbpq, puwkdhtpbf - irnorifmdm)
-
01 Apr 2025
xwwhkpngis(sbyjukxspq) = wowxenupmi plxmnhgqli (egmgqtgbpq, phegjcukft - igghenvurv)
Phase 3
-
Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted)Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted)
ygwrgoodke(gvmmjzclfo) = urbslmwews psogzvbqyc (nsjetbbhim )
Positive
08 Oct 2024
Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted)Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted)
(Season one)
ygwrgoodke(gvmmjzclfo) = gahkiloqyr psogzvbqyc (nsjetbbhim )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free